<110>    Industry-Academic Corporation Foundation Yonsei University

<120>    Composition for Preventing or Treating of Obesity, Dyslipidemia,
         Fatty Liver or Insulin Resistance Syndrome Comprising  Camphene
         as Active Ingredients

<150>    KR10-2009-0022937
<151>    2009-03-18

<160>    16

<170>    KopatentIn 1.71

<210>    1
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Forward primer of peroxisome proliferator activated receptor
         gamma 2


<400>    1
ttcggaatca gctctgtgga                                                     20


<210>    2
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Reverse primer of peroxisome proliferator activated receptor
         gamma 2


<400>    2
ccattgggtc agctcttgtg                                                     20


<210>    3
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Forward primer of adipocyte protein2


<400>    3
agcatcataa ccctagatgg                                                     20


<210>    4
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Reverse primer of adipocyte protein2


<400>    4
gaagtcacgc ctttcataac                                                     20


<210>    5
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Forward primer of CCAAT/enhancer binding protein alpha


<400>    5
tcggtgcgtc taagatgagg                                                     20


<210>    6
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Reverse primer of CCAAT/enhancer binding protein alpha


<400>    6
tcaaggcaca tttttgctcc                                                     20


<210>    7
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Forward primer of TNF-alpha


<400>    7
tgtctcagcc tcttctcatt                                                     20


<210>    8
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Reverse primer of TNF-alpha


<400>    8
agatgatctg agtgtgaggg                                                     20


<210>    9
<211>    25
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Forward primer of Interleukin 6


<400>    9
atgaagttcc tctctgcaag agact                                               25


<210>    10
<211>    24
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Reverse primer of Interleukin 6


<400>    10
cactaggttt gccgagtaga tctc                                                24


<210>    11
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Forward primer of uncoupling protein 1


<400>    11
gggacctaca atgcttacag                                                     20


<210>    12
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Reverse primer of uncoupling protein 1


<400>    12
ggtcatatgt caccagctct                                                     20


<210>    13
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Forward primer of uncoupling protein 3


<400>    13
acggatgtgg tgaaggtccg                                                     20


<210>    14
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Reverse primer of uncoupling protein 3


<400>    14
tacaaacatc atcacgttcc                                                     20


<210>    15
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Forward primer of Glyceraldehyde-3-phosphatedehydrogenase


<400>    15
agaacatcat ccctgcatcc                                                     20


<210>    16
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Reverse primer of Glyceraldehyde-3-phosphatedehydrogenase


<400>    16
tccaccaccc tgttgctgta                                                     20
